Related Experiment Video

Updated: Jun 15, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
08:28

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Published on: February 15, 2022

Role of somatic mutations in vascular disease formation

Sarah M Weakley1, Jun Jiang, Panagiotis Kougias

  • 1Michael E DeBakey Department of Surgery, Molecular Surgeon Research Center, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA.

Expert Review of Molecular Diagnostics
|March 11, 2010
PubMed

Insights

Somatic mutations in DNA may drive vascular diseases like atherosclerosis and Alzheimer's. Further research into genetic targets could lead to personalized genomic medicine for these conditions.

Area of Science:

  • Cardiovascular Science
  • Genetics
  • Oncology

Background:

  • Coronary artery disease, cerebrovascular disease, pulmonary artery hypertension, and Alzheimer's disease cause significant morbidity and mortality.
  • Current treatments for these vascular diseases are limited.
  • The hypothesis that vascular diseases are neoplastic processes, driven by somatic mutations, has been debated for decades.

Purpose of the Study:

  • To investigate the role of somatic mutations in the development of vascular diseases.
  • To explore the involvement of DNA damage, oxidative stress, and TGF-beta receptor signaling in atherogenesis.
  • To identify potential genetic targets for future personalized genomic medicine.

Main Methods:

  • Analysis of DNA damage and mutagenesis in genomic and mitochondrial DNA within atherosclerotic and vascular lesions.
  • Examination of oxidative stress markers.
  • Investigation of signaling pathways involving the TGF-beta receptor family.

Main Results:

  • Evidence suggests that somatic mutations are involved in atherogenesis and vascular disease development.
  • Mitochondrial DNA damage and oxidative stress are implicated in these processes.
  • Specific genetic targets in disease pathogenesis are being identified.

Conclusions:

  • Somatic mutations play a role in the pathogenesis of major vascular diseases.
  • Understanding these genetic underpinnings is crucial for developing effective treatments.
  • Genome sequencing advancements facilitate the search for personalized genomic medicine approaches for vascular diseases.

More Related Videos

A Patient-Derived Xenograft Model for Venous Malformation06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...